Non-alcoholic Fatty Liver Disease
📧 Sign up to get email alerts when something new happens for Non-alcoholic Fatty Liver Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-09-18Clinical Trial Update: Empagliflozin Versus Statins in Non-Alcoholic Fatty Liver Disease [Phase 4]
Phase 4 clinical trial evaluating empagliflozin versus statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis is li…
-
CLINICAL_TRIALS research · 2025-09-15Clinical Trial Update: Non-Invasive MASLD Diagnosis & T2D Remission Biomarkers
Ongoing clinical trial evaluating non-invasive methods for diagnosing metabolic dysfunction-associated steatotic liver disease (MASLD) and i…
-
CLINICAL_TRIALS research · 2025-08-28Clinical Trial Update: Effect of Amino Acids on Hepatic Fat Content in Adolescents (AMINOS Study) [Phase 3]
Phase 3 clinical trial evaluating amino acids for reducing hepatic fat in adolescents with hepatic steatosis and non-alcoholic fatty liver d…
-
CLINICAL_TRIALS research · 2025-08-22Clinical Trial Update: Fibrosis Lessens After Metabolic Surgery [Phase 4]
Phase 4 clinical trial update exploring metabolic surgery to reduce liver fibrosis in metabolic dysfunction-associated steatotic liver disea…
-
CLINICAL_TRIALS research · 2025-08-19Clinical Trial Update: Mediterranean Diet in Familial Mediterranean Fever: Is Fatty Liver Affected by Addition of Aerobic Exercise [NA]
Clinical trial evaluating whether adding aerobic exercise to a Mediterranean diet affects fatty liver in individuals with Familial Mediterra…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-08-15Clinical Trial Update: Evaluation of a New Ultrasound System for the Non-invasive Assessment of Liver Steatosis in MASLD/MASH Patients [NA]
Ongoing clinical trial evaluating a new ultrasound system for non-invasive assessment of liver steatosis in MASLD/MASH patients.
-
CLINICAL_TRIALS research · 2025-08-03Clinical Trial Update: A Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Patients With Non-alcoholic Fatty Liver Disease (NAFLD), MAESTRO-NAFLD-Open-Label-Extension (MAESTRO-NAFLD-OLE) [Phase 3]
Clinical trial update for a Phase 3 open-label extension (MAESTRO-NAFLD-OLE) of resmetirom (MGL-3196) in non-alcoholic fatty liver disease, …
-
CLINICAL_TRIALS research · 2025-08-03Clinical Trial Update: Assessment of Tolerability of Specialized Food Products Made Out of Vegetable Protein and Their Influence on Lipid Profile in Patients With Non-alcoholic Fatty Liver Disease [NA]
A clinical trial update describes a planned study to assess tolerability of vegetable-protein-based specialized foods and their effect on li…
-
CLINICAL_TRIALS research · 2025-07-23Clinical Trial Update: Development of a Non-invasive Screening Tool to Predict Metabolic Dysfunction-associated Steatotic Liver Disease
A clinical trial update reports recruiting participants to evaluate a non-invasive screening tool for predicting metabolic dysfunction-assoc…
-
CLINICAL_TRIALS research · 2025-07-22Clinical Trial Update: Harnessing Macrophage Lysosomal Lipid Metabolism in Obesity (ATM)
A clinical trial investigating macrophage lysosomal lipid metabolism in obesity is currently recruiting, with obesity, non-alcoholic fatty l…
-
CLINICAL_TRIALS research · 2025-07-09Clinical Trial Update: Characteristics of NAFLD Among Type 2 Diabetes Patients [NA]
This clinical trial update describes characteristics of non-alcoholic fatty liver disease among patients with type 2 diabetes, and the study…
-
CLINICAL_TRIALS research · 2025-07-03Clinical Trial Update: Randomized Double Blinded Placebo-Controlled w/Semaglutide to Prevent Weight Gain After Liver Transplant [Phase 2]
Phase 2 randomized, double-blind, placebo-controlled trial of semaglutide to prevent weight gain after liver transplantation in patients wit…
-
CLINICAL_TRIALS research · 2025-06-15Clinical Trial Update: NeuroFLiPP: Parametric PET of Neuroinflammation in Fatty Liver Disease [EARLY_Phase 1]
Clinical trial update for NeuroFLiPP, an early Phase 1 study using parametric PET to image neuroinflammation in non-alcoholic fatty liver di…
-
CLINICAL_TRIALS research · 2025-06-13Clinical Trial Update: Influence of the Diversity and Composition of the Microbiota in the Development of Pediatric Fatty Liver [NA]
A completed clinical trial investigating how the gut microbiota's diversity and composition may influence the development of pediatric non-a…
-
CLINICAL_TRIALS research · 2025-06-03Clinical Trial Update: Investigating Pathological Mechanisms in Non-alcoholic Fatty Liver Disease
A clinical trial at Queen Mary University of London is investigating pathological mechanisms in non-alcoholic fatty liver disease and is cur…
-
CLINICAL_TRIALS research · 2025-05-25Clinical Trial Update: Pioglitazone and Empagliflozin for Fatty Liver Disease in Type 2 Diabetes [Phase 4]
A Phase 4 clinical trial is evaluating pioglitazone plus empagliflozin for fatty liver disease in people with type 2 diabetes and is current…
-
CLINICAL_TRIALS research · 2025-05-16Clinical Trial Update: Reversal of Lipid-Induced Insulin Resistance [NA]
A clinical trial update indicating that a study on reversing lipid-induced insulin resistance is currently recruiting. The conditions includ…
-
CLINICAL_TRIALS research · 2025-05-15Clinical Trial Update: Establishment of NAFLD Cohort and Development of Fibrosis Markers
The update describes establishment of a non-alcoholic fatty liver disease (NAFLD) cohort and development of biomarkers to assess liver fibro…
-
CLINICAL_TRIALS research · 2025-05-02Clinical Trial Update: Relationship Between Eating Patterns, Body Composition and the Detection of Fatty Liver in Children and Adolescents With Trisomy 21: LiverTy Project
Ongoing LiverTy clinical trial in children and adolescents with Down syndrome investigates how eating patterns and body composition relate t…
-
CLINICAL_TRIALS research · 2025-04-30Clinical Trial Update: Mechanisms of Macrophage Polarization in HIRI in Patients With NAFLD
This clinical trial update describes research into how macrophages polarize during hepatic ischemia-reperfusion injury in patients with non-…
-
CLINICAL_TRIALS research · 2025-04-24Clinical Trial Update: Elucidating Hepatic Metabolism in Non-alcoholic Fatty Liver Disease
This clinical trial update describes an ongoing study at Helsinki University Central Hospital to investigate hepatic metabolism in non-alcoh…
-
CLINICAL_TRIALS research · 2025-04-22Clinical Trial Update: Multi-morbidity Screening in People With Type 2 Diabetes and Pre Diabetes
A clinical trial registry entry describes a multi-morbidity screening study in people with type 2 diabetes mellitus and prediabetes, examini…
-
CLINICAL_TRIALS research · 2025-04-10Clinical Trial Update: Evaluate the Efficacy and Safety of LivPhcD Capsules in the NAFLD Subjects [NA]
A clinical trial is recruiting to evaluate the efficacy and safety of LivPhcD Capsules in subjects with non-alcoholic fatty liver disease.
-
CLINICAL_TRIALS research · 2025-04-03Clinical Trial Update: Elucidating Shared Mechanisms Contributing to NAFLD and PsA Disease Severity With Guselkumab Therapy [NA]
This clinical trial explores shared mechanisms contributing to non-alcoholic fatty liver disease and psoriatic arthritis severity and evalua…
-
CLINICAL_TRIALS research · 2025-03-28Clinical Trial Update: Liver Steatosis in Pediatric CD Patients
A clinical trial update from the University of Palermo describes a study on liver steatosis in children with celiac disease; the study is no…